Patents by Inventor Stephen F. Anderson

Stephen F. Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220089700
    Abstract: Monoclonal antibodies, or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease.
    Type: Application
    Filed: November 30, 2021
    Publication date: March 24, 2022
    Inventors: Stephen F. Anderson, Natalie Anosova, Nicola Beltraminelli, Pierre Garrone, Harold Kleanthous, Majid Mehtali, Jianxin Zhang
  • Patent number: 11220537
    Abstract: Monoclonal antibodies, or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: January 11, 2022
    Assignee: SANOFI PASTEUR BIOLOGICS, LLC
    Inventors: Stephen F. Anderson, Natalie Anosova, Nicola Beltraminelli, Pierre Garrone, Harold Kleanthous, Jianxin Zhang, Majid Mehtali
  • Publication number: 20190153078
    Abstract: Monoclonal antibodies, or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease.
    Type: Application
    Filed: November 29, 2018
    Publication date: May 23, 2019
    Inventors: Stephen F. Anderson, Natalie Anosova, Nicola Beltraminelli, Pierre Garrone, Harold Kleanthous, Jianxin Zhang, Majid Mehtali
  • Patent number: 10160797
    Abstract: Monoclonal antibodies or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile ) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile -associated disease. C. difficile is a gram positive, anaerobic bacterium that causes gastrointestinal disease in humans. The bacteria are transmitted through feces and spread to food and other surfaces when people who are infected do not thoroughly wash their hands.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: December 25, 2018
    Assignee: SANOFI PASTEUR BIOLOGICS, LLC
    Inventors: Stephen F. Anderson, Natalie Anosova, Nicola Beltraminelli, Pierre Garrone, Harold Kleanthous, Jianxin Zhang, Majid Mehtali
  • Publication number: 20160068591
    Abstract: Monoclonal antibodies or antigen-binding fragments thereof that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease. C. difficile is a gram positive, anaerobic bacterium that causes gastrointestinal disease in humans. The bacteria are transmitted through feces and spread to food and other surfaces when people who are infected do not thoroughly wash their hands.
    Type: Application
    Filed: March 14, 2014
    Publication date: March 10, 2016
    Applicant: Sanofi Pasteur Biologics, LLC
    Inventors: Stephen F. ANDERSON, Natalie ANOSOVA, Nicola BELTRAMINELLI, Pierre GARRONE, Harold KLEANTHOUS, Jianxin ZHANG, Majid MEHTALI
  • Patent number: 4563672
    Abstract: In a microprocessor controlled fire alarm system, a chain of continuous pulses is generated by the microprocessor. The chain of continuous pulses is monitored, and if there is an interruption in the chain of continuous pulses a signal is generated to automatically reset the microprocessor.
    Type: Grant
    Filed: February 7, 1984
    Date of Patent: January 7, 1986
    Assignee: Wormald U.S., Inc.
    Inventor: Stephen F. Anderson